Literature DB >> 11483818

A 1000-fold overdose of clonidine caused by a compounding error in a 5-year-old child with attention-deficit/hyperactivity disorder.

M J Romano1, A Dinh.   

Abstract

A 5-year-old child who weighed 17.5 kg received 50 mg of clonidine. The amount ingested was confirmed by analysis of the suspension administered (clonidine HCl 9.78 mg/mL). To our knowledge, this represents the largest ingestion in a child and the largest ingestion on a milligram per kilogram basis in the medical literature. The child's initial presentation included hyperventilation, an unusual feature of clonidine toxicity. The child was discharged without sequela 42 hours after admission. A serum concentration of clonidine 17 hours postingestion was 64 ng/mL, the highest reported to date in a pediatric patient. The intoxication was traced to a pharmacy compounding error in which milligrams were substituted for micrograms. Increased prescribing of clonidine in young children coupled with the requirement to compound clonidine in a suspension and the narrow therapeutic index suggests that the frequency of severe ingestions in children will increase in the future.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11483818     DOI: 10.1542/peds.108.2.471

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  16 in total

1.  Retention of compounding skills among pharmacy students.

Authors:  John G Eley; Christine Birnie
Journal:  Am J Pharm Educ       Date:  2006-12-15       Impact factor: 2.047

2.  Dermal exposure to a compounded pain cream resulting in severely elevated clonidine concentration.

Authors:  Adam C Pomerleau; Casey E Gooden; Corinne R Fantz; Brent W Morgan
Journal:  J Med Toxicol       Date:  2014-03

Review 3.  U.S. Compounding Pharmacy-Related Outbreaks, 2001-2013: Public Health and Patient Safety Lessons Learned.

Authors:  Nadine Shehab; Megan N Brown; Alexander J Kallen; Joseph F Perz
Journal:  J Patient Saf       Date:  2018-09       Impact factor: 2.844

4.  Raman Spectroscopy: A Sensitive and Specific Technique for Determining the Accuracy of Compounded Pharmaceutical Formulations.

Authors:  Claudia Meek; Jihye Hoe; Jason Evans; Rosanne Thurman; Lisa Ashworth; Richard Leff
Journal:  J Pediatr Pharmacol Ther       Date:  2016 Sep-Oct

Review 5.  Pharmacologic Treatment of Opioid Use Disorder: a Review of Pharmacotherapy, Adjuncts, and Toxicity.

Authors:  Michael S Toce; Peter R Chai; Michele M Burns; Edward W Boyer
Journal:  J Med Toxicol       Date:  2018-10-30

6.  Approach to the pediatric prescription in a community pharmacy.

Authors:  Sandra Benavides; Donna Huynh; Jill Morgan; Leslie Briars
Journal:  J Pediatr Pharmacol Ther       Date:  2011-10

7.  Oral clonidine pretreatment prior to venous cannulation.

Authors:  David L Hall; Ehsan Rezvan; Dimitris N Tatakis; John D Walters
Journal:  Anesth Prog       Date:  2006

Review 8.  Description of outbreaks of health-care-associated infections related to compounding pharmacies, 2000-12.

Authors:  Catherine Staes; Jason Jacobs; Jeanmarie Mayer; Jill Allen
Journal:  Am J Health Syst Pharm       Date:  2013-08-01       Impact factor: 2.637

9.  Toxicity from a clonidine suspension.

Authors:  Mariya Farooqi; Steven Seifert; Susan Kunkel; Mary Johnson; Blaine Benson
Journal:  J Med Toxicol       Date:  2009-09

Review 10.  Overdose of drugs for attention-deficit hyperactivity disorder: clinical presentation, mechanisms of toxicity, and management.

Authors:  Henry A Spiller; Hannah L Hays; Alfred Aleguas
Journal:  CNS Drugs       Date:  2013-07       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.